Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01987180 · ClinicalTrials.gov registry record

Using Smartphones in the Neonatal Intensive Care Unit

A clinical trial of Self Efficacy, sponsored by Northwestern University.

Completed
Registry status
90
Enrollment target
1
Study location

NCT01987180: Completed study of Self Efficacy, sponsored by Northwestern University.

NCT01987180 is a study of Self Efficacy that has completed, run by Northwestern University. The registered enrollment target is 90 participants, below the 151-participant average among 30 other Self Efficacy trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01987180, a study of Self Efficacy, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
90 participants
Enrollment target
1
Study location

Study Summary

The goal of this research is to develop and pilot the NICU-2-Home service, a health information technology (IT) concept centered on a smart phone app. NICU-2-Home will provide support to parents of very low birth weight (VLBW) infants as they transition from the NICU to their homes and eventually establish a medical home with the infant's pediatrician. Once the app is developed, we will conduct a feasibility study with randomization to pilot test the ability of NICU-2-Home app to (a) improve parent's self-efficacy and confidence in caring for their VLBW infant, (b) decrease parental stress, and (c) enhance involvement with their VLBW infants compared to controls.

Primary Outcome

Parents will be asked to provide saliva samples at four different days (the day prior to discharge, the day after discharge, five days after discharge, and 2 weeks after discharge) at the following three times each day: when they wake up, 30 minutes later, and at bedtime.

Conditions Studied

Study Locations (1)

Illinois

  • Prentice Women's Hospital - Chicago

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2013-01
Est. Completion 2015-06
Northwestern University

1,209 total trials

What the finished NCT01987180 record still lists

NCT01987180 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 151-participant average among 30 other Self Efficacy trials with a reported enrollment target (40% lower).

The record links to 1 condition, with Self Efficacy appearing as the primary indexed condition, and to 0 interventions.

NCT01987180 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01987180 about?

NCT01987180 is a clinical study titled "Using Smartphones in the Neonatal Intensive Care Unit". The goal of this research is to develop and pilot the NICU-2-Home service, a health information technology (IT) concept centered on a smart phone app. NICU-2-Home will provide support to parents of very low birth weight (VLBW) infants as they transition from the NICU to their homes and eventually es...

What is the current status of trial NCT01987180?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2013-01. Estimated completion is 2015-06.

What conditions does trial NCT01987180 study?

This clinical trial studies the following conditions: Self Efficacy.

Who is sponsoring clinical trial NCT01987180?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01987180 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Self Efficacy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01987180's enrollment target sits among peer trials

90 15th of 30 higher than 15 of 30 other Self Efficacy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Self Efficacy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01987180, the US trial registry maintained by the National Library of Medicine. NCT01987180 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.